About T-complex protein 11 homolog
T-complex protein 11 homolog (TCP11) is a protein
from Homo sapiens identified by UniProt accession
Q8WWU5, 503 residues long.
MolForge cross-references it against 0 known binders and
58 disease associations.
Target properties
| Protein name | T-complex protein 11 homolog |
| UniProt accession | Q8WWU5 |
| Gene | TCP11 |
| Organism | Homo sapiens |
| Length | 503 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (58)
Diseases linked to this target (Open Targets).
- body height · score 0.34
- smoking cessation · score 0.28
- wheezing · score 0.28
- FEV/FVC ratio · score 0.26
- C-reactive protein measurement · score 0.25
- vital capacity · score 0.22
- eosinophil percentage of leukocytes · score 0.21
- osteoarthritis, knee · score 0.19
- total joint arthroplasty · score 0.19
- osteoarthritis, hip · score 0.19
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q8WWU5-F1 | alphafold | PREDICTED | 77.66 | — |
Amino-acid sequence (503 residues)
MPDVKESVPP KYPGDSEGRS CKPETSGPPQ EDKSGSEDPP PFLSVTGLTE TVNEVSKLSN KIGMNCDYYM EEKVLPPSSL EGKVKETVHN AFWDHLKEQL SATPPDFSCA LELLKEIKEI LLSLLLPRQN RLRIEIEEAL DMDLLKQEAE HGALKVLYLS KYVLNMMALL CAPVRDEAVQ KLENITDPVW LLRGIFQVLG RMKMDMVNYT IQSLQPHLQE HSIQYERAKF QELLNKQPSL LNHTTKWLTQ AAGDLTMSPP TCPDTSDSSS VAGPSPNEAA NNPEPLSPTM VLCQGFLNLL LWDLENEEFP ETLLMDRTRL QELKSQLHQL TVMASVLLVA SSFSGSVLFG SPQFVDKLKR ITKSLLEDFH SRPEEAILTV SEQVSQEIHQ SLKNMGLVAL SSDNTASLMG QLQNIAKKEN CVCSVIDQRI HLFLKCCLVL GVQRSLLDLP GGLTLIEAEL AELGQKFVNL THHNQQVFGP YYTEILKTLI SPAQALETKV ESV
Explore T-complex protein 11 homolog with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets